Dr. Michael Thomas Lecompte, MD

Dr. Lecompte practices at UNC Health Rex in Raleigh, North Carolina, part of University of North Carolina Health Care System.

Dr. Lecompte's NPI, 1588923593, was assigned on May 10, 2012. Dr. Lecompte holds North Carolina license 2019-02156.

Dr. Lecompte's primary practice is UNC Health Rex, at 4420 Lake Boone Trail, Raleigh, NC 27607 in Wake County. The practice phone is (919) 784-3100.

Dr. Lecompte's primary practice is UNC Health Rex in Raleigh, North Carolina, part of University of North Carolina Health Care System. Dr. Lecompte is also affiliated with Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Lecompte to 1 more clinical lab and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lecompte practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Lecompte's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Lecompte's licenses on file in 2 states: North Carolina and Missouri.

CMS data shows 270 Medicare services from Dr. Lecompte across 6 procedure codes in 2024, for 210 Medicare patients. Medicare paid $26,255 for them.

CMS counts 210 Medicare patients who saw Dr. Lecompte in 2026. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lecompte's median patient age at 73, with 51% women.

In 2026, Dr. Lecompte wrote 101 Medicare Part D claims for 48 patients. 65% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $30,921 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

Dr. Lecompte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lecompte as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Lecompte, published from 2016 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Postoperative Complications, Carcinoma, Pancreatic Ductal and Pancreatic Neoplasms. Dr. Lecompte has published most often in Am Surg. Dr. Lecompte's most frequent co-authors are Hong Kim, MD, Ryan Courtney Fields, MD and Elizabeth Moran Gleeson, MD.

CMS Open Payments shows 95 general payments to Dr. Lecompte from 18 drug and device companies from 2018 to 2025. Education make up the largest share, 51% of the total. Intuitive Surgical, Inc. paid the most, $18,907.